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Immunoglobulin G1 (IgG1)-based therapies are
widespread, and many function through interactions
with low-affinity Fc g receptors (FcgR). N-glycosyla-
tion of the IgG1 Fc domain is required for FcgR bind-
ing, though it is unclear why. Structures of the
FcgR:Fc complex fail to explain this because the
FcgR polypeptide does not bind the N-glycan. Here
we identify a link between motion of the N-glycan
and Fc:FcgRIIIa affinity that explains the N-glycan
requirement. Fc F241 and F243 mutations decreased
the N-glycan/polypeptide interaction and increased
N-glycan mobility. The affinity of the Fc mutants for
FcgRIIIa was directly proportional to the degree of
glycan restriction (R2 = 0.82). The IgG1 Fc K246F mu-
tation stabilized the N-glycan and enhanced affinity
for FcgRIIIa. Allosteric modulation of a protein/pro-
tein interaction represents a previously undescribed
role for N-glycans in biology. Conserved features
suggesting a similar N-glycan/aromatic interaction
were also found in IgD, IgE, and IgM, but not IgA.
INTRODUCTION
The fragment crystallizable (Fc) of human immunoglobulin G1
(IgG1) engages Fc g receptors (FcgRs) displayed on the surface
of immune cells. In an adaptive immune response, Fc links the
target-specific recognition of antigen binding fragments (Fabs)
to a proinflammatory cascade, resulting in destruction of the
invading pathogen (Janeway et al., 2008).
IgG1 Fc contains a conserved asparagine-linked carbohy-
drate (N-glycan) that is required for productive engagement of
the low-affinity FcgRs (Jefferis, 2009; Lux et al., 2013). The
IgG1 Fc N-glycan is heterogeneous in nature as a result of the
template-independent synthesis of carbohydrates in the Golgi
(reviewed in Varki, 2009). Despite this source of compositional
variability, a relatively small number of Fc glycoforms are
observed and are predominantly of a core fucosylated, bianten-
nary complex type with low levels of terminal sialic acid modifi-
cation (Arnold et al., 2007).
The FcN-glycan composition correlates strongly with rheuma-
toid arthritis (RA) disease state and is dominated by ungalactosy-1478 Structure 22, 1478–1488, October 7, 2014 ª2014 Elsevier Ltd Alated forms in patients with advanced disease (Parekh et al.,
1985). Furthermore, changes in glycan distribution can be
observed years before RA symptoms arise (Ercan et al., 2010),
and glycan anomalies return to normal during pregnancy-
induced remission (Alavi et al., 2000; Bondt et al., 2013). The
Fc N-glycan is predominantly of a biantennary complex type
with a high level of core fucosylation (Figure 1). It was suggested
that native sialic acid modification, which converts proinflamma-
tory Fc to a potently anti-inflammatory form, is prevented when a
galactose (Gal) residue at the nonreducing termini of the glycan
is absent (Anthony et al., 2008; Kaneko et al., 2006). RA is amulti-
factorial disease, and though it is not known if IgG N-glycan
anomalies cause RA, it is known that compositional changes
to the Fc N-glycan alter FcgRIIIa affinity (Okazaki et al., 2004;
Yamaguchi et al., 2006).
Structural models of IgG1 Fc show the N-glycan interacting
with the Fc polypeptide surface between the Cg2 domains (Fig-
ure 1A; Deisenhofer, 1981; Huber et al., 1976). Surprisingly, the
glycan termini were distal to the site of FcgRIIIa binding (Fig-
ure 1B; Mizushima et al., 2011; Sondermann et al., 2000), and
it seems unlikely that direct interactions between the branch
termini of the Fc N-glycan and the proinflammatory FcgRIIIa
explain how composition differences at the Fc N-glycan termini
affect Fc:FcgRIIIa affinity (Yamaguchi et al., 2006). A different
model must be used to explain this phenomenon.
Solution nuclear magnetic resonance (NMR) spectroscopy
and molecular dynamics simulations revealed significant mo-
tions of the Fc N-glycan (Barb et al., 2012; Barb and Prestegard,
2011; Frank et al., 2014), which was unexpected considering the
fixed N-glycan position observed by X-ray crystallography
(Huber et al., 1976). These opposing observations agreed in
one key aspect: the a1–6 branch of the N-glycan interacts with
amino acid residues on the Fc polypeptide surface. Motions of
the Fc Cg2 domain motion also occur (Frank et al., 2014; Krapp
et al., 2003; Saphire et al., 2002) and may be related to N-glycan
motion.
NMR spectroscopy provides a direct measurement of molec-
ular motion with atom-level resolution. Though a single peak,
corresponding to a resonance frequency, for each of the two
Gal 13C2 nuclei was observed, further NMR analysis revealed
that each peak represented the population-weighted average
of two distinct states (Barb and Prestegard, 2011). The (a1–6
branch)Gal residue showed the greatest effects of this intercon-
version and was found to exchange between a polypeptide-
bound state and an unrestricted, mobile state on a ms timescale.
Each resonance in each state is characterized by a distinctll rights reserved
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Figure 1. Homodimeric IgG1 Fc Binds to Monomeric FcgRIIIa
(A) Homodimeric IgG1 Fc (blue ribbon diagram) binds to monomeric FcgRIIIa
(orange ribbons) (Sondermann et al., 2000).
(B) Interactions between F241 and F243 amino acid side chains stabilize the
N-glycan in structures of Fc determined by X-ray crystallography. The Fc
N-glycan is shown with a black stick model. An FcgRIIIa N-glycan contacts
core Fc N297 glycan residues and is shown with an orange stick model
(Mizushima et al., 2011).
(C) Three Fc glycoforms are examined in this study: a complex-type, bian-
tennary N-glycan containing two [13C2]-galactose(Gal) residues at the
nonreducing termini (G2F-Fc), a single N-acetylglucosamine residue (GlcNAc-
Fc), and Fc with a disaccharide (Fuc-GlcNAc-Fc). Carbohydrate residues are
represented using the CFG convention (Varki, 2009) (GlcNAc, blue square; Gal,
yellow circle; fucose(Fuc), red triangle; mannose(Man), green circle); a1–6 and
a1–3 linkages to the branching mannose are shown that differentiate the two
branches of the glycan.
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinityresonance frequency that is largely determined by covalent
bonds in the Gal moiety and the immediate nonbonded chemical
environment (within 5 A˚). Both the rate of exchange and the dif-
ference in the resonance frequencies for each state contributed
to line broadening relaxation (R2) of the glycan resonances (Barb
and Prestegard, 2011; Cavanagh, 2007).
Two Fc amino acid residues likely restrict Fc N-glycan
mobility (Lund et al., 1996; Voynov et al., 2009; Yu et al.,
2013) and contribute to stabilizing the polypeptide-bound state
of the N-glycan (Barb and Prestegard, 2011). F241 and F243
are found at the IgG1 Fc N-glycan/polypeptide interface
and >7 A˚ from the nearest FcgRIIIa residue (Figure 1B). F241
is positioned beneath the branch point mannose residue, and
F243 interacts only with the glycan’s a1–6 branch (Figures 1B
and 1C). Mutations at these positions increased the level of
Gal and sialic acid incorporation at these positions (Lund
et al., 1996; Voynov et al., 2009; Yu et al., 2013). Kelly and co-
workers determined that aromatic residues formed higher affin-
ity interactions with a glycan than other amino acids types
(Chen et al., 2013). Though hydrophobic effects were measur-
able, the dispersion component of CH-p interactions contrib-
uted a greater proportion of free energy to the interaction.
This observation highlights F241 and F243 as targets for muta-
tion to disrupt the interface.Structure 22, 1478–Based on recent reports (Barb et al., 2012; Barb and Preste-
gard, 2011; Frank et al., 2014; Krapp et al., 2003; Malhotra
et al., 1995; Yamaguchi et al., 1998), we propose that confor-
mational oscillations of the Fc Cg2 domains and N-glycans
are integral to FcgR binding and vary between naturally occur-
ring glycoforms. Such a dynamic system endows IgG-express-
ing B cells with the capacity to tune FcgR affinity by changing
glycan composition and would explain why serum IgG N-glycan
composition changes rapidly in response to injury or disease
(Lauc et al., 2013; Novokmet et al., 2014). If this model of Fc
motion is accurate, one expects an Fc N-glycan with Gal on
the a1–6 branch to experience less motion than an N-glycan
lacking this Gal, and an Fc N-glycan with an N-acetylglucos-
amine residue (GlcNAc) on the a1–6 branch to experience
less motion than an N-glycan lacking this GlcNAc. The restric-
tion in both cases is due to extended glycan/polypeptide inter-
actions. It is unclear how a1–3 branch modification might affect
glycan/polypeptide interactions. This supposition is supported
by the observation that Fc with longer glycans binds FcgRIIIa
with higher affinity (Yamaguchi et al., 2006); the effect of sialy-
lation, an extending modification, on receptor affinity is unre-
solved (Kaneko et al., 2006; Yu et al., 2013), though recent ev-
idence suggests that sialylation does not alter either N-glycan
motion or the interface character to a large extent (Barb
et al., 2012; Crispin et al., 2013). To simplify analysis of the rela-
tionship between dynamics and affinity, we generated a series
of Fc mutants with alterations at the N-glycan/polypeptide
interface and remodeled the N-glycans in vitro to near homoge-
neity. Here we report the N-glycan mobility and receptor bind-
ing affinity for these Fc mutants.
RESULTS
Fc Mutations Increase Glycan Modification during
Expression
We prepared F241I, F243I, and F241I/F243I Fc mutants to
disrupt CH-p interactions but preserve hydrophobic contacts
and F241S, F243S, and F241S/F243S Fc mutants to disrupt
both CH-p and hydrophobic contacts. Matrix-assisted laser
desorption ionization mass spectrometry (MALDI-MS) analysis
of N-glycans from purified Fc mutants showed a broader distri-
bution of glycoforms and a greater degree of modification than
those from wild-type (WT) Fc (Figure 2 and Figure S1 available
online). Though complex-type, core fucosylated, biantennary
types were the predominant glycans from all proteins, the double
mutants contained triantennary glycans, extensive sialylation, as
well as increased fucosylation. Glycan distributions from F241S/
F243S and single F241 and F243mutants shared similarities with
published reports (Lund et al., 1996; Voynov et al., 2009; Yu
et al., 2013). These triantennary and branch-fucosylated glyco-
forms are not found on IgG1 Fc from human serum (Arnold
et al., 2007). The single mutant proteins showed degrees of
modification that were intermediate between WT and the two
Fc double mutants. One explanation for the increased diversity
of glycans on mutant Fc offered by Lund et al. (1996) is that
removing aromatic side chains reduced glycan/polypeptide in-
teractions and decreased steric occlusion of the glycan. This
would lead to greater glycan exposure and greater modification
by glycosyltransferases in the Golgi during protein expression.1488, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1479
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Figure 2. MALDI Mass Spectrometry of PNGaseF-Released, Permethylated N-Glycans Shows the Increased Diversity of Glycans from Fc
Mutants when Compared with Wild-Type
Cartoon diagrams highlight potential configurations that fit the observed masses and known N-glycan structures; isobaric ions were not distinguished. Peaks
corresponding to Na+ and K+ adducts are observed for each species.
See also Figure S1.
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IgG1 Fc N-Glycan Motion and FcgRIIIa AffinityAlternative explanations include increased retention in the Golgi
or protein misfolding.
Fc Mutants with Homogenous N-Glycans Are Well
Folded
The increased diversity of Fc mutant glycoforms introduces a
significant challenge because N-glycan composition changes
FcgRIIIa affinity and potentially Fc quaternary structure (Kaneko
et al., 2006; Krapp et al., 2003; Yamaguchi et al., 2006; Yu et al.,
2013). To reduce the effect of heterogeneity, N-glycans fromWT
and mutant Fc were enzymatically remodeled in vitro to contain
60%–95% of the G2F glycoform (Figures 1C, S2, and S3).
All Fc proteins were judged using 1H NMR spectroscopy to be
well folded following in vitro glycan remodeling (data not shown).
Furthermore, each protein is bound to a Protein A affinity resin,
which binds Fc through a protein-protein interaction and re-
quires appropriately folded Fc (data not shown). Disulfide bonds
that link the hinge region and stabilize the Fc dimer also formed
(Figure S4).
Heteronuclear single quantum coherence (HSQC) spectra
provide high-resolution information regarding protein tertiary1480 Structure 22, 1478–1488, October 7, 2014 ª2014 Elsevier Ltd Astructure. We found that the 2d 1H-15N HSQC spectrum of
[15N-tyrosine(Y)]-Fc F241S/F243S was nearly identical to that
of [15N-Y]-Fc WT (Figure 3), indicating that the Cg2 and Cg3
domains of both proteins are similarly folded. One difference be-
tween the spectra was the disappearance of the Y300 peak in
the Fc F241S/F243S spectrum. Y300 occupies the same loop
as the glycan tether residue, asparagine(N)-297, and the Y300
resonance is sensitive to changes in the structure and motion
of the loop (Figure 1B; Matsumiya et al., 2007; Yamaguchi
et al., 2006).
Fc Mutants with a G2F N-Glycan Exhibit Reduced
FcgRIIIa Binding
Folded Fc WT and Fc mutants, remodeled to contain a high pro-
portion of G2F N-glycans, bound to a soluble fragment of glyco-
sylated human FcgRIIIa. We found the FcWT:FcgRIIIa affinity, as
measured by surface plasmon resonance (SPR; 0.55 ± 0.05 mM),
isothermal titration calorimetry (ITC; 1.2 ± 0.1 mM), and a protein
A resin-based pull down assay (0.5 mM), was similar to reported
values (0.1–2 mM;Kaneko et al., 2006; Yamaguchi et al., 2006; Yu
et al., 2013)). Singlemutant proteins showed 3- to 4-fold reducedll rights reserved
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Figure 3. 1H-15N HSQC Spectra of (15N-Tyr)-Fc WT and (15N-Tyr)-Fc
F241S/F243S Are Nearly Identical
1H-15N HSQC Spectra of (15N-Tyr)-Fc WT (black contours) and (15N-Tyr)-Fc
F241S/F243S (red contours) are nearly identical.
Peaks from residues Y300 and Y349 show differences in the mutant spectrum
and are highlighted with a vertical arrow. Peak assignments are known
(Matsumiya et al., 2007).
Table 1. Equilibrium FcgRIIIa Dissociation Constants for Fc WT
and Mutants from SPR Experiments
IgG1 Fc FcgRIIIa KD (mM) ± Error
G2F glycan
WT 0.55 0.05
F241I 2.1 0.2
F241S 1.5 0.5
F243S 1.9 0.3
F241I F243I 10 1
F241S F243S 29 3
K246F 0.34 0.06
GlcNAc glycan
WT 2.4 0.2
F241I F243I 6.3 0.6
F241S F243S 3.5 0.9
No glycan T299A nb –
Each observation represents the average of three independent
measurements ± SD of the mean. n.b., no binding detected.
Structure
IgG1 Fc N-Glycan Motion and FcgRIIIa Affinityaffinity by SPR when compared with Fc WT and the double
mutant proteins bound with a 20- to 60-fold less affinity than
WT (Table 1). A previous study found a similar binding effect
with single F241A and F243A mutants (Yu et al., 2013). These
data are noteworthy because the effect of glycan heterogeneity
has been removed by efficient in vitro glycan remodeling to a
physiologically relevant form. The trend of FcgRIIIa binding by
Fc mutants also mirrored the MALDI-MS data that showed
greater N-glycan modification during expression for Fc double
mutants and intermediate degrees observed for the single mu-
tants (Figure 2).F241/F243 Fc Mutations Do Not Affect GlcNAc-
Fc:FcgRIIIa Affinity
An enzymatically truncated Fc glycoform was prepared that
provided a mechanism to test the role of the F241 and F243 mu-
tations. It was reported that deglycosylated Fc and Fuc-GlcNAc-
Fc (Figure 1C) bound FcgRIIIa below the levels of detectability
(Yamaguchi et al., 2006). However, we found that a similar
form, GlcNAc-Fc (Figure 1C), bound to FcgRIIIa with robust affin-
ity (2.4 ± 0.2 mM; Table 1). This binding is likely enhanced by the
absence of the core fucose residue, which reduced FcgRIIIa
affinity 30- to 50-fold in studies using a complex-type, core-
fucosylated biantennary Fc N-glycan (Mizushima et al., 2011;
Okazaki et al., 2004).
Equilibrium dissociation constants for the GlcNAc-Fc glyco-
forms of Fc WT and both Fc double mutants showed similar
values (Table 1), indicating that the F241 and F243 mutations
only affect the glycan/polypeptide interface and do not disturb
other features of the Fc-FcgRIIIa interaction. A different Fc
variant, containing only a T299A mutation to prevent N-glycosyl-
ation, did not bind FcgRIIIa under these conditions. Crispin and
coworkers recently demonstrated that F241 and F243mutations
also affect FcgRIIIa binding of IgG1 Fc with a Man5 glycan (YuStructure 22, 1478–et al., 2013). Our data confirm that F241 and F243 affect FcgRIIIa
affinity through the extended N-glycan and do not impact other
aspects of binding.
F241/F243 Fc Mutations Increase N-Glycan Motion
The N-glycan occupies at least two distinct states that can be
characterized by NMR spectroscopy. Each peak position repre-
sents the population-weighted average of a polypeptide-bound
state and an unrestricted, mobile state (Barb and Prestegard
2011). Therefore, we expect to see changes in both NMR peak
positions and R2 relaxation for any mutant with an altered N-
glycan/polypeptide interface. Based on the distance between
the F241 and F243 side chains from the Gal residues (12 and
6 A˚, respectively, from (a1–6 branch)Gal 13C2), we do not expect
to alter, to a large extent, the Gal chemical environment that con-
tributes to the observed resonance frequencies of the individual
states.
We measured the resonance frequencies of Gal-13C2 nuclei
on Fc mutants that were remodeled to display nearly homoge-
nous G2F N-glycans. Unlike WT Fc (Barb and Prestegard,
2011; Yamaguchi et al., 1998), 1H-13C HSQC spectra of proteo-
lyzed Fc, degraded to remove long-range N-glycan/polypeptide
interactions, and both of the double mutant proteins showed a
single peak that contained contributions from both (a1–3 branch)
and (a1–6 branch)Gal residues. This result indicated the contri-
bution of the polypeptide-bound state to the observed reso-
nance frequencies was minimal and the population was skewed
toward the high mobility, unrestricted state (Figure 4A; Table 2).
Spectra of F241I, F241S, and F243S proteins each contained
two major resolved peaks and in that aspect were similar to WT;
however, the position of these peaks was different (Figure 4).
Peaks from the a1–6 branch were found in a position between
that of the WT Fc (a1–6 branch)Gal C2 and that of proteolyzed
Fc, and peaks from the a1–3 branch were found in a position be-
tween that of the WT Fc (a1–3 branch)Gal C2 and that of proteo-
lyzed Fc. As mentioned previously, we anticipate that the muta-
tions do not directly affect Gal resonance frequencies. These1488, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1481
A B
Figure 4. FcMutations Impact the Structure
and Mobility of N-Glycan Termini as Judged
by Solution NMR Spectroscopy
(A) Peaks from both N-glycan branches migrate
incrementally away from those of the corre-
sponding Fc WT peak and toward that of proteo-
lyzed Fc. Spectra, from which this plot was
generated, are shown in Figure S5.
(B) The degree of line broadening for the (a1–6
branch)Gal 13C2 (black squares) correlates
strongly with the resonance frequency (R2 = 0.95),
indicating that the frequency is sensitive to glycan
mobility (R2 for a1–3 = 0.36; open circles). Points
from (a1–3 branch)Gal and (a1–6 branch)Gal
measurements are denoted with open circles or
filled squares, respectively. Peakswith overlapped
signals are marked with a half-open circle/half-fil-
led square. Error bars represent 1 SD of the mean.
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinityresults indicate that N-glycans from each of the single Fc mu-
tants exhibit reduced, but still measureable, interactions with
the Fc polypeptide when compared with WT Fc. The peak posi-
tions thus reflect a population-weighted average that was shifted
toward the more mobile state (Barb and Prestegard, 2011).
Signal intensities for the double Fcmutants observed in 1d 13C
and 2d HSQC spectra were stronger than those of the single mu-
tants, which in turn were stronger than FcWTdespite similar pro-
tein concentrations during the experiments (data not shown).
One explanation for this is that signals from mutant proteins
experience less magnetization decay during the experiment.
We measured the longitudinal and line broadening transverse
relaxation rates (R1 and R2, respectively) that describe signal
loss when the bulk magnetization vector is parallel or perpendic-
ular to the external magnetic field, respectively. These relaxation
rates report local molecular motions of Fc on fast (<20 ns [Barb
and Prestegard, 2011]; R1 and R2) and slow timescales (ms-ms;
R2 only). Longitudinal relaxation rates did not show a clear
response to the mutations (Table 2). Transverse relaxation rates
from Gal-13C2 nuclei on mutant Fc were less than those of WT
(Table 2) and showed a strong correlation with peak position
for the (a1–6 branch)Gal 13C2 of the N-glycan (R2 = 0.95; Fig-
ure 4B). These values are also consistent with the observed in-
crease in signal intensity. Furthermore, the relaxation rates are
entirely consistent with measurements of the resonance fre-
quencies that showed the decreased influence of polypeptide/
N-glycan interaction.
N-glycans on Fc double mutant proteins showed transverse
relaxation rates that were highly similar to those of proteolyzed
Fc, indicating undetectable levels of line-broadening relaxation
due to exchange between the two previously identified N-glycan
states. This is likely due to increased N-glycan motions faster
than the ms timescale, which were previously shown to
contribute to line broadening (Barb et al., 2012; Barb and Preste-
gard, 2011). We do not believe that the rate of motion was
reduced to a timescale of s; in this case, we would expect to
observe two peaks for each Gal 13C2 nucleus corresponding
to each state.
Transverse relaxation rates for both a1–3 and a1–6Man-linked
Gal 13C2 nuclei were inversely correlated with FcgRIIIa affinity1482 Structure 22, 1478–1488, October 7, 2014 ª2014 Elsevier Ltd A(R2 = 0.55 and 0.82, respectively) (Figure 5), indicating that
reducing the N-glycan/polypeptide interactions increased
glycan motion and reduced Fc:FcgRIIIa affinity. 13C2 resonance
frequencies (Table 2) and N-glycan distributions (Figure 2) also
showed a high correlation with FcgRIIIa affinity.
Stabilizing the Fc N-Glycan Enhances Affinity
for FcgRIIIa
Removing N-glycan/polypeptide interactions led to increased
N-glycan mobility and decreased FcgRIIIa affinity. Therefore,
strengthening the glycan/polypeptide interface should enhance
affinity. Previous data showed a stronger glycan/polypeptide
interaction at lower temperature (Barb and Prestegard, 2011);
however, temperature likely also influences other aspects of
Fc binding FcgRIIIa. We again pursued an approach utilizing
Fc mutation and in vitro N-glycan remodeling to test whether
an increased interface would lead to higher FcgRIIIa affinity.
The positively charged side chain of lysine(K)246 is positioned
directly adjacent to the (a1–6 branch)Gal residue in structures of
IgG1 Fc (Deisenhofer, 1981) and is thought to influence the reso-
nance frequencies of (a1–6 branch)Gal nuclei (Barb and Preste-
gard, 2011). Fc K246F was prepared to determine whether a
glycan-stabilizing interaction could be formed at this position.
Fc K246F with a G2F glycan bound FcgRIIIa with a 1.6-fold
higher affinity than WT Fc (Table 1).
NMR spectroscopy of the 13C2-Gal-labeled Fc K246F showed
that the (a1–3 branch)Gal 13C2 nucleus had a greater chemical
shift value than that of Fc WT, indicating a less mobile N-glycan
(Figure 6A). Two very broad and weak peaks corresponding to
the (a1–6 branch)Gal 13C2 nucleus were observed. The reso-
nance frequency and relaxation rate of this nucleus are more
difficult to interpret than those measured with F241/F243 Fc mu-
tants because K246 is close (<4 A˚), and thus, mutations could be
expected to alter (a1–6 branch)Gal 13C2 resonance frequency
directly, unlike our expectation for the F241 and F243 mutations.
However, the position of the (a1–3 branch)Gal 13C2 peak shows
a strong correlation to FcgRIIIa affinity for the corresponding Fc
(Figure 6B). Though the mechanism by which N-glycan mobility
influences (a1–3 branch)Gal 13C2 resonance frequency is not
known, this nucleus is a reliable indicator of total N-glycanll rights reserved
Table 2. NMR Chemical Shift and Relaxation Parameters Measured at 16.4T
IgG1 Fc Branch
Spin Relaxation Frequency
R1 (s
1) ± Error R2 CP (s
1) ± Error 1H (ppm) 13C (ppm)
WT a1–3 1.46 0.17 23.81 1.70 3.659 73.913
a1–6 1.50 0.24 63.82 5.86 3.442 75.368
F241I a1–3 1.22 0.13 24.02 1.01 3.601 73.869
a1v6 1.10 0.32 32.65 3.61 3.430 74.630
F241S a1v3 1.26 0.06 28.09 1.37 3.577 73.830
a1–6 0.97 0.10 36.47 2.08 3.470 74.420
F243S a1–3 1.50 0.10 19.98 1.55 3.616 73.873
(a1–6)? nd nd 3.520 73.856
F241I F243I degenerate 1.42 0.20 16.14 0.87 3.527 73.766
F241S F243S degenerate 1.59 0.07 17.51 0.42 3.541 73.771
Proteolyzed degenerate 1.63 0.04 10.25 0.44 3.491 73.770
nd, analysis inconclusive because of likely peak overlap.
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinitymobility (R2 = 0.79) due to the presumed lack of direct contact
between the N-glycan’s a1–3 branch and the Fc polypeptide.
DISCUSSION
The Effects of N-Glycan Mobility and FcgRIIIa Affinity
Here we demonstrate that Fc restricts N-glycan motion through
interactions with the F241 and F243 residues. We also found that
the extent of Fc N-glycan/polypeptide interactions as measured
by NMR correlated directly to FcgRIIIa affinity and that the F241/
F243 mutations only affected FcgR binding when the G2F N-
glycan was present. Stabilizing N-glycan motion through the
K246F mutation showed the expected increase in FcgRIIIa affin-
ity for this mutant.
These data reveal a previously undescribed role for N-glycans.
N-glycans influence protein folding, stability, and pharmacoki-
netic properties andalso contain epitopes for specific recognition
by many classes of receptors (reviewed in Varki, 2009). Here we
provideanextensivecharacterizationof apreviously undescribed
role: anN-glycan influences a primarily protein/protein interaction
through an allostericmechanism that utilizes an extensive glycan/
polypeptide interface to restrict N-glycan motion.
There are two nonexclusive models that explain how Fc
N-glycan mobility affects affinity for FcgRIIIa. First, F241 and
F243 provide contacts that restrict the medial and distal N-
glycan residues (relative to the N297 linkage site) and thus lock
the N297-bearing Fc loop into a position that is optimal for con-
tact with FcgRIIIa. The disappearance of the Y300 peak in the
1H-15N-HSQC spectrum of the Fc F241S/F243S mutant is
consistent with this model (Figures 1A and 3). Second, it has
been suggested that Fc Cg2 domain orientation is an important
component of FcgRIIIa affinity and may be sensitive to N-glycan
structure or mobility (Krapp et al., 2003). Unrestricted Fc N-gly-
cans are in a position to occupy the space between the Cg2 do-
mains and force these domains farther apart than is optimal for
FcgRIIIa binding. Motions of the Fc Cg2 domains relative to
one another as observed in 200 ns molecular dynamics simula-
tions proved more extensive than previously shown by X-ray
crystallography and are likewise consistent with this possibility
(Frank et al., 2014).Structure 22, 1478–The sensitivity of FcgRIIIa affinity to Fc N-glycan mobility sug-
gests a potentially interesting feature of IgG: the interaction with
low-affinity FcgRs can be tuned in subtle ways. The advantages
of this system are many, including the potential for a rapid cell-
mediated response. In most cases, protein:protein interactions
are only modulated over generations through genetic modifica-
tion. Evidence for the existence of such a system comes from
the identification of rapid changes in the IgG N-glycome in
response to stress (Lauc et al., 2013; Novokmet et al., 2014),
B-cell stimuli (Wang et al., 2011), and the identification of IgG
N-glycan modification by ST6GalI, resulting in a potently anti-in-
flammatory circulating form of Fc that occurs primarily outside
the Golgi and in the serum (Jones et al., 2012). The balance point
between proinflammatory and anti-inflammatory agents must be
constantly shifting to maintain sensitivity to eliminate infection
but avoid autoimmune disorders.
Feature Conservation in IgD, E, G, and M
The role of the Fc N-glycan may not be a unique feature of IgG1.
A strong interaction of IgG2-4 with low-affinity FcgRs also re-
quires the N-glycan (Lux et al., 2013). IgD, IgE, and IgM also
have an N-glycosylation site analogous to N297 of IgG1 and
contain an aromatic residue at the same position as IgG1 F241
(Figures 7 and S6). Though evidence for the role of these features
is sparse for IgD, IgE, and IgM, compelling evidence hints at a
similar mechanism.
The structure of the IgE Fc:FcεRIa complex is remarkably
similar to the IgG1 Fc:FcgRIIIa complex, sharing the FcεR bind-
ing that occurs asymmetrically at the top of two IgE Fc domains
with 1:1 FcεR:Fc stoichiometry (Figure 7; Garman et al., 2000).
IgE contains an N-glycan at N394, analogous to IgG1 N297,
that is predominantly of a mannose type, representative of
incomplete Golgi-mediated processing in contrast to other
IgE N-glycans (Arnold et al., 2004; Dorrington and Bennich,
1978) and also required for FcεRIa binding (Nettleton and
Kochan, 1995). IgD and IgM N-glycans at positions N354
and N402, respectively, corresponding to IgG1 N297, are
likewise predominantly of mannose types, unlike other N-gly-
cans on the same protein (Figure S6; Arnold et al., 2005).
It is unclear whether the conserved aromatic residue and1488, October 7, 2014 ª2014 Elsevier Ltd All rights reserved 1483
AB
Figure 6. A Mutation Designed to Enhance the Interaction between
the Glycan and Polypeptide Increases Affinity for FcgRIIIa
(A) An 1H-13C HSQC spectrum of K246F mutant of Fc at 50C containing the
G2F glycan with 13C2-enriched Gal termini is shown. Positions of wild-type
coherences are highlighted in each spectrum with ‘‘+’’ signs, and the position
of coherences following trypsin proteolysis ismarkedwith ‘‘x.’’ To the left of the
2d HSQC spectrum, 1d 13C spectra of WT at K246F glycans are shown.
(B) The resonance frequency of (a1–3 branch)Gal 13C2 nuclei correlates with
FcgRIIIa affinity (R2 = 0.79). Error bars represent 1 SD of the mean.
A B
Figure 5. The Degree of Line Broadening for the (a1–3 branch)Gal
13C2 or (a1–6 branch)Gal 13C2 Nuclei Correlates with FcgRIIIa Bind-
ing Affinity
The degree of line broadening (R2) for the (a1–3 branch)Gal
13C2(A) or (a1–6
branch)Gal 13C2 (B) nuclei correlates with FcgRIIIa binding affinity. Standard
deviations of the mean are included for both dimensions. The R2 for the same
nucleus on a proteolyzed Fc fragment is shown for comparison to provide an
experimental lower bound (dashed gray line). The coefficient of determination
(R2) of a line fitted to each data set is 0.55 (A) and 0.82 (B). Error bars represent
1 SD of the mean.
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinityglycan/polypeptide interactions contribute to restricted IgD,
IgE, and IgM N-glycan processing at these sites, but the de-
gree of structural and functional conservation is remarkable.
IgD, IgE, and IgM also have F or Y at a position identical to
F241 of IgG1 (Figure 7), although only IgG has an aromatic
amino acid at the +2 position (F243). IgE, interestingly, has an
F residue at the V262 position of IgG1 that is on the beta strand
neighboring the F243 position of IgG1 and could potentially
interact with the a1–6 branch of the N-glycan. This suggests,
if the glycan-polypeptide interfaces for these immunoglobulins
all form similarly, that an aromatic amino acid restricts the
N-glycan in IgD, IgE, IgG, and IgM, though IgE and IgG have
an aromatic amino acid positioned to form an additional inter-
action to restrict a1–6 branch residues.
Of the human Ig isotypes, only IgA does not contain these fea-
tures; IgA has neither an N-glycan nor aromatic residue at sites
corresponding to IgG1 N297 and F241. However, the FcaRI rec-
ognizes IgA Fc by a completely different mechanism than that
described above. FcaRI binds symmetrically to the IgA Ca3
domain (analogous to IgG Cg3) with a 2:1 FcaR:Fc stoichiometry
(Figure 7; Herr et al., 2003). Although IgA lacks the N-glycan/
aromatic residue features, inter-heavy-chain disulfide bonds
are present and are expected to exert conformational restric-
tions on the Ca2 domains.
Conclusions
This previously undescribed connection between IgG N-glycan
motion and FcgRIIIa affinity revealed why IgG FcN-glycosylation
is required. As a result, we foundmethods to tune antibody affin-
ity, developed an Fc form that binds tighter than WT, and high-
lighted avenues for future discovery, including how the ensemble
of Fc conformations in solution are shaped by the N-glycan and
investigating how glycan/polypeptide interactions influence the
structure and activity of other Ig isotypes.1484 Structure 22, 1478–1488, October 7, 2014 ª2014 Elsevier Ltd AEXPERIMENTAL PROCEDURES
Materials
All materials were purchased from Sigma-Aldrich unless otherwise noted.
Structure figures were prepared using the PyMOL software package
(Schro¨dinger).
Protein Expression
Human IgG1-Fc (residues 216–447) with a 25-residue trypanosome signal
peptide (Vandersall-Nairn et al., 1998) appended to the N terminus was cloned
into theNotI and HindIIII sites of the pGen2 vector (Barb et al., 2012). Plasmids
encoding IgG1 Fc mutations F241I, F241S, F243I, F243S, K246F, T299A,
F241I/F243I, or F241S/F243S were made according to the QuikChange
method (Agilent Technologies). All mutations were confirmed by DNA
sequencing (ISU DNA Facility). The extracellular region of FcgRIIIa (residues
19–193, V158 allotype) containing N-terminal 83 histidine and green fluores-
cent protein (GFP) tags and a Tobacco etch virus protease digestion site
was cloned into the EcoRI and HindIII sites of the pGen2 vector (Barb et al.,
2012).
Proteins were expressed during a transient transfection of HEK293F (Life
Technologies) or HEK293S (lec1/) cells (Backliwal et al., 2008a, 2008b;
Barb et al., 2012; Reeves et al., 2002). Cells grown in FreeStyle293 medium
(Life Technologies) on a shaker (ATR Biotech) at 125 RPM with 8% CO2 andll rights reserved
Figure 7. N-Glycosylation and an Aromatic
Residue at a Comparable Position Are
Conserved Features of IgD, E, G, and M
Of the human immunoglobulins, only IgA does not
share these features; however, the IgA1:FcaRI
interaction is remarkably different. The structure of
receptor (orange ribbon) Fc (white ribbon) com-
plexes is shown based (PDB 1E4K [Sondermann
et al., 2000], PDB: 1F6A [Garman et al., 2000],
PDB: 1OW0 [Herr et al., 2003]). At the bottom, an
amino acid alignment, based on IgG1 Fc
numbering, is highlighted to show conserved ar-
omatic residues and N-glycosylation sequons.
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinity80% humidity at 37C were transfected at a density of 2.5 3 106 live cells
per ml with 2.5 mg/ml DNA and 7.5–9.0 mg/ml PEI. Cells were diluted 1:1
after a 24 hr incubation with FreeStyle293 medium supplemented with
4.4 mM valproic acid. Transfected cells were harvested after 6 days by
centrifugation at 1000 g for 5 min. FcgRIIIa was purified using a Ni-NTA
column (QIAGEN). Expressed Fc fragments were purified using a Protein
A-Sepharose Column.
Fc glycoproteins expressed in human HEK293F cells to high levels
(50 mg/ml) with the exception of F243I, which expressed repeatedly at
low levels. Expression medium was centrifuged to remove cells and debris
and was then loaded onto a Protein A-Sepharose Column and washed
with three column volumes of 25 mM 3-(N-morpholino)propanesulfonic
acid (MOPS), 0.1 M sodium chloride (pH 7.2). Protein was eluted with
0.1 M glycine (pH 3.0) into collection tubes containing 1.0 M trisaminome-
thane (TRIS) (pH 8.0), equal to one half of the elution volume and was then
immediately buffer exchanged with 25 mM MOPS (pH 7.2), 0.1 M sodium
chloride using 15 ml of 10 kDa molecular weight cutoff Amicon Ultra centrif-
ugal filters (Millipore). Amino acid-selective labeling of IgG1-Fc was achieved
by supplementing custom FreeStyle293 expression medium without lysine,
phenylalanine, and tyrosine with labeled [15N]-tyrosine, unlabeled l-lysine,
and unlabeled l-phenylalanine at 100 mg/l based on the average concentra-
tion of these amino acids in DMEM (Dulbecco and Freeman, 1959). Stock
concentrations of L-lysine (40 mg/ml), L-phenylalanine (20 mg/ml), and
L-tyrosine (1.5 mg/ml) were prepared in 10 mM TRIS (pH 8.0) and filter
sterilized.Structure 22, 1478–1488, October 7, 2014 ªHEK293S cells were maintained in Freestyle
293 expression medium supplemented with
10% ExCell medium. Transient transfection of
HEK293S cells was performed only in Freestyle
293 medium. The dilution 24 hr after transfection
was performedwith Freestyle 293medium supple-
mented with 20% ExCell medium.
Enzymatic Remodeling for 13C Enrichment
of IgG1-Fc N-Glycans
Following purification, 13C2-labeled galactose was
added to the Fc N-glycan termini as described
previously (Barb and Prestegard, 2011). IgG1-Fc
(35 mg) in a 50 mM ammonium acetate (pH 6.0)
buffer was treated with neuraminidase (0.5 U/ml)
and b-1,4-galactosidase (0.08 U/mL; New England
Biolabs). Samples were purified as described
above and exchanged into 20 mM MOPS buffer
(pH 7.2), 0.1 M sodium chloride, and 20 mM man-
ganese chloride. Reactions were incubated for
24–48 hr following addition of b-1,4-galactosyl-
transferase and UDP-13C2-Galactose. Reaction
completion was confirmed by MALDI MS. Sam-
ples were further washed with 5% or 100% D2O
(Cambridge Isotopes) NMR buffer (20 mM sodium
phosphate [pH 7.2], 0.1 M sodium chloride,0.5 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid [DSS]) by centrifugation
using 0.5 ml of 10 kDa molecular weight cutoff Amicon Ultra centrifugal filters
(Millipore) to remove MnCl2, UDP, and unreacted UDP-
13C2-galactose.
Preparation of Fc Glycoforms Consisting of Only a Single GlcNAc
Residue
IgG1-Fc andmutants expressed in HEK293S cells were exchanged with 0.1 M
potassium phosphate buffer (pH 6.0). Any higher forms of N-glycans were
truncated to generate unfucosylated single N-acetylglucosamine (GlcNAc)
glycoform by enzymatic cleavage with Endo-b-N-acetylglucosaminidase F1
(EndoF1) using 1:50 enzyme:protein concentration in the dark at room temper-
ature for 16–18 hr. EndoF1-treated Fc was further purified using Protein A-Se-
pharose Column as described above and buffer exchangedwith 20mMMOPS
(pH 7.2), 0.1 M sodium chloride. The digestion reactions were judged to be
complete using SDS-PAGE and MALDI-MS.
NMR Spectroscopy
NMR spectra were collected using 4 mm Shigemi NMR tubes in a spectrom-
eter equipped with a cryogenically cooled probe and an Avance II console
(Bruker) and operating at 50C and 16.4 T. Fc dimer concentrations were be-
tween 0.20.5 mM in a final volume of 150 mL. 1H-15N HSQC NMR spectra
were collected over 64 3 2048 complex points in the t1 3 t2 time-domain di-
mensions (1420 Hz) with approximately 768 scans per free induction decay
(FID). The spectral digital resolution was 45 Hz. 1H-13C HSQC NMR spectra
were collected over 256 3 2048 complex points in the t1 3 t2 time-domain2014 Elsevier Ltd All rights reserved 1485
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IgG1 Fc N-Glycan Motion and FcgRIIIa Affinitydimensions (3520 Hz) with approximately 128 scans per FID. The spectral dig-
ital resolution was 27.5 Hz.
The relaxation parameters R1 and R2(CP) for the Gal-
13C2 nuclei were
measured as described previously (Barb et al., 2012). Data were analyzed us-
ing Topspin (version 3.2), NMRviewJ (One Moon Scientific), NMRPipe (Dela-
glio et al., 1995), and the Gnuplot (v. 4.6) software packages. Chemical shifts
were reference directly (1H) and indirectly (13C, 15N) to the internal DSS stan-
dard at 0.07 ppm (1H).
Glycans Analysis by Mass Spectroscopy
IgG-Fc N-glycans were released and analyzed as described previously (Anu-
mula and Taylor, 1992; Barb et al., 2009) using matrix-assisted laser-desorp-
tion ionization time-of-flight mass spectrometry (MALDI-TOFMS) on a
Voyager-DE PRO (Applied Biosystems).
Binding Analysis of Fc and Fc Mutants with FcgRIIIA
SPR
GFP-FcgRIIIa was immobilized on the surface of a CM5 S Series chip using
primary amine coupling in flow cells 2, 3, and 4 with a BiaCore T100 system
(GE Healthcare). Flow cell 1 was left uncoupled as a reference cell. IgG1
Fc:FcgRIIIa dissociation constants were measured in triplicate by analysis
of SPR response at equilibrium following subtraction of the signal from the un-
coupled reference cell at 25C. At least five concentrations of each sample
were injected onto the chip surface at a flow rate of 5 ml/min with a contact
time of 420 s and a dissociation time of 420 s. Chip regeneration was
achieved by applying 10 ml of 100 mM Glycine (pH 3.0) in 30 s. Dissociation
constants (KD) were determined by fitting Equation 1 to equilibrium response
values,
RUeq =RUmax=ð1+KD=½FcÞ; (Equation 1)
where RUeq is the measured response at equilibrium, [Fc] is the IgG1 Fc con-
centration, RUmax is the response when the chip is saturated with Fc.
ITC
ITC measurements were performed using a MicroCal iTC200 system (GE
Healthcare). All measurements were done at 25C in a buffer composed of
25mMMOPS, 100mMNaCl (pH 7.4); 166 mM IgG1 Fc (as a dimer) was titrated
into 20 mMGFP-FcgRIIIa using 183 2 ml injectionswith a spacing time of 3min.
Two control experiments were performed, one by titrating IgG1 Fc into buffer
and the other by titrating buffer into GFP-FcgRIIIa. Binding isotherms were
created with the MicroCal iTC200 Origin software (GE Healthcare). The
data from IgG1 Fc-Buffer and Buffer-FcgRIIIa titration experiments were sub-
tracted from the IgG1 Fc-FcgRIIIa titration data to account for heat changes
resulting from nonbinding interactions. The resulting binding isotherm and
dissociation constant were fit using a 1:1 Fc:FcgR ratio.
Protein A-Sepharose Bead-Based Method
First, protein A sepharose beads were washed extensively with a buffer con-
taining 25 mM MOPS, 100 mM NaCl, and 0.25 mg/ml BSA (pH 7.4). Washed
beads were suspended in a volume of buffer such that the resulting slurry
was 50% (vol/vol) beads. GFP-FcgRIIIa (0, 0.1, 0.3, 1, 3, and 6 mM) was
mixed with IgG1 Fc (0, 0.1, 0.3, 1, 3, and 6 mM) and incubated at room tem-
perature for 5 min. After incubation, protein A beads were added. The
mixture was incubated at room temperature for 3 minutes with periodic
gentle vortexing to ensure a homogenous bead distribution. Supernatant
was then separated from the beads following centrifugation at 500 g. Super-
natant fluorescence was measured using a Cary Eclipse Fluorescence Spec-
trophotometer (Agilent Technologies) (ex-484 nm em-510 nm). The fraction
of fluorescence bound to the beads at each point was determined by
comparing to the total amount of fluorescence in a reaction without Fc
added. Dissociate constants (KD) were determined by fitting Equation 2 to
fractional occupancy data:Fractional Occupancy =
ð½FcgRIIIa+ ½Fc+KDÞ 
ﬃﬃﬃﬃ
ð½F
q
2
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